We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Evolv Technologies Holdings Inc | NASDAQ:EVLV | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.1471 | -3.51% | 4.0429 | 4.14 | 4.21 | 4.30 | 4.115 | 4.25 | 1,114,568 | 00:25:10 |
Issuer:
|
ValueVision Media, Inc. | |
|
||
Nasdaq Global Market Symbol:
|
VVTV | |
|
||
Securities offered by
ValueVision: |
4,900,000 shares of our common stock | |
|
||
Price to public:
|
$3.75 per share | |
|
||
Underwriting discount and
commissions per share:
|
$0.225 | |
|
||
Estimated net proceeds to
ValueVision (after underwriting
discounts and commissions and
estimated offering expenses):
|
$17,022,500 | |
|
||
Trade date:
|
December 17, 2010 | |
|
||
Closing date:
|
December 22, 2010 | |
|
||
Common stock outstanding after
the offering*: |
37,712,201 | |
|
||
Over-allotment option:
|
None | |
|
||
Underwriter:
|
Piper Jaffray & Co. | |
|
||
Use of proceeds:
|
We intend to use the net proceeds from this offering for working capital and general corporate purposes, which may include capital expenditures, as well as payment to the holder of our Series B Preferred Stock in connection with the cash sweep payment obligations under the terms of our Series B Preferred Stock. In addition, we may pay $2.5 million to the holder of our Series B Preferred Stock to obtain their consent to the issuance of shares to NBCU in May 2011. See the section titled "Use of Proceeds" beginning on page S-7 of the prospectus supplement. |
* | Based on 32,812,201 shares of common stock outstanding as of the close of business on December 15, 2010 and excludes, as of the close of business on December 15, 2010: | |
| 2,491,195 shares of common stock issuable upon the exercise of outstanding options under our 2004 Omnibus Stock Plan, with a weighted average exercise price of $5.75 per share; | |
| 1,696,325 shares of common stock issuable upon the exercise of outstanding options under our 2001 Omnibus Stock Plan, with a weighted average exercise price of $6.03; | |
| 525,000 shares of common stock issuable upon the exercise of outstanding stock options issued to certain employees outside the Omnibus Stock Plans, with a weighted average exercise price of $3.58; and | |
| warrants to purchase up to 6,000,000 shares of common stock and warrants to purchase up to 14,744 shares of common stock issued to issued to GE Capital Equity Investments, Inc. (GE Equity) and NBC Universal, Inc. (NBCU), respectively, in connection with our strategic alliance with GE Equity and NBCU; and | |
| $4 million of our common stock to be issued to NBCU on May 15, 2011. |
| on an actual basis; and | ||
| on an as adjusted basis to give effect to our sale of 4,900,000 shares of common stock at an offering price of $3.75 per share, after deducting an assumed underwriting discount and estimated offering expenses of $250,000 payable by us ($125,000 of which constitute fees and expenses of the underwriter that we have agreed to pay). |
As of October 30, 2010 | |||||||||
Actual | As | ||||||||
Adjusted | |||||||||
(In thousands) | |||||||||
Cash and cash equivalents
|
$ | 15,674 | $ | 32,697 | |||||
Restricted cash and investments
|
4,961 | 4,961 | |||||||
|
|||||||||
Long-term payable
|
$ | 1,937 | $ | 1,937 | |||||
Accrued dividends Series B Preferred Stock
|
8,903 | 8,903 | |||||||
Series B Mandatory Redeemable Preferred Stock, $.01 per share par
value, 4,929,266 shares authorized; 4,929,266 shares issued and
outstanding
|
12,531 | 12,531 | |||||||
|
|||||||||
Shareholders Equity:
|
|||||||||
Common Stock, $0.01 per share par value; 100,000,000 shares authorized
Actual 32,796,077 shares outstanding
As adjusted 37,696,077 shares outstanding
|
$ | 328 | $ | 377 | |||||
Warrants to purchase 6,022,115 shares of common stock
|
637 | 637 | |||||||
Additional paid-in capital
|
318,932 | 335,906 | |||||||
Accumulated deficit
|
(253,859 | ) | (253,859 | ) | |||||
Total shareholders equity
|
$ | 66,038 | $ | 83,061 | |||||
|
|||||||||
Total capitalization
|
$ | 89,409 | $ | 106,432 |
Public offering price per share
|
$ | 3.75 | |||||||
Historical net
tangible book value
per share as of
October 30, 2010
|
1.96 | ||||||||
Increase in historical
net tangible book
value per share
attributable to
investors
participating in this
offering
|
0.20 | ||||||||
|
|||||||||
As adjusted historical net tangible
book value per share after this
offering
|
2.16 | ||||||||
|
|||||||||
Dilution per share to investors
participating in this offering
|
$1.59 | ||||||||
|
1 Year Evolv Technologies Chart |
1 Month Evolv Technologies Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions